Dolaren

Quick links to important sections

Dolaren

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dolaren

Quick Facts

Property Description
Active ingredient Acetaminophen, Diclofenac, Ibuprofen
Form Oral formulation (e.g., tablet)
Pharmacological class Analgesic, Antipyretic, Anti-inflammatory agent
Common use Pain, fever, and inflammation relief
Origin Synthetic medicine

Core Definition and Pharmacological Classification

Dolaren is a synthetic medicinal preparation designed as a Fixed-Dose Combination (FDC) product for the concurrent management of pain, fever, and inflammation. It is formally classified as a combination of an Analgesic, an Antipyretic, and an Anti-inflammatory agent, utilizing a multi-modal mechanism to address multiple discomfort pathways.

The product employs a strategic combination of two Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)—Diclofenac and Ibuprofen—and a Para-aminophenol derivative, Acetaminophen. This multi-class strategy indicates that combining agents with distinct mechanisms can be utilized to provide comprehensive symptomatic relief.

Composition and Pharmaceutical Form of the Drug

The formulation is defined by the inclusion of three globally recognized active ingredients: Acetaminophen (Paracetamol), Diclofenac, and Ibuprofen. All three are distinct, synthetic substances. The product is designed for oral administration and is typically presented as an oral formulation, such as a tablet. This preparation is distinct due to the inclusion of two different NSAIDs, making it a unique, three-way combination in managing acute symptoms like those associated with severe muscle strain or complex pain.

The General Purpose of This Multi-Modal Approach

The general purpose of this specific three-way combination is to provide enhanced symptomatic control by addressing different facets of discomfort simultaneously. The concurrent application of multiple agents is a strategy in pain management intended to manage the triad of pain, fever, and associated inflammation effectively. The benefit of this multi-modal approach is the potential to offer robust relief against complex symptoms that may not respond sufficiently to single-agent therapy. This principle shows that combining these agents provides a more robust approach to managing various types of acute discomfort.

What side effects are possible with Dolaren?

Possible Side Effects and Safety Information

The safety profile for Dolaren (which contains diclofenac) is defined by mandatory regulatory warnings for serious, potentially fatal adverse events, and a spectrum of effects categorized by the body system affected and frequency.

Serious Adverse Reactions and Black Box Warnings

Official regulatory documents emphasize a Black Box Warning for two major, life-threatening risks:

  • Cardiovascular Thrombotic Events: The medicine may increase the risk of serious, potentially fatal cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. This risk can occur early in treatment and may increase with duration of use and higher doses.
  • Gastrointestinal (GI) Events: Serious GI inflammation, bleeding, ulceration, and perforation of the stomach or intestines have been reported. These events can occur without warning symptoms and may be fatal, particularly in older adults.

System-Organ-Class Adverse Reactions

Adverse reactions are classified by the body system impacted. Common reactions, occurring in a higher percentage of users, often affect the Gastrointestinal System (e.g., abdominal pain, indigestion, nausea) and the Nervous System (e.g., headache). Other documented serious effects involve the Hepatic System (liver failure), Renal System (kidney damage, including papillary necrosis), and the Hemic and Lymphatic System (e.g., anemia, agranulocytosis).

Safety Restrictions and Contraindications

The medicine is Contraindicated and must not be used if there is a known hypersensitivity or allergic-type reaction (e.g., asthma, urticaria) to diclofenac, aspirin, or other NSAIDs. It is also Contraindicated for the treatment of pain right before or after coronary artery bypass graft (CABG) surgery. Due to potential fetal harm, use in pregnant women should be avoided, especially late in pregnancy. For all patients, the risk of serious adverse events is minimized by using the lowest effective dose for the shortest duration necessary.

Overdose and Emergency Response

Overdose and when to seek help

Any suspected or known overdosage of Dolaren requires immediate medical attention. This urgent action is mandated regardless of the presence or absence of initial symptoms, due to the risk of delayed toxicity associated with the Acetaminophen component.

Documented Overdose Manifestations
Early Signs Nausea, vomiting, abdominal pain, pallor, dizziness, and drowsiness are commonly documented early signs.
Severe Outcomes Life-threatening risks include hepatic necrosis and hepatic failure, acute renal failure, gastrointestinal bleeding, seizures, and coma.

Official regulatory protocols require contacting emergency services or a poison control center immediately. The specific antidote, N-acetylcysteine (NAC), is available for the Acetaminophen component, though no specific antidote is known for the NSAID components. Management involves the timely administration of NAC and symptomatic and supportive treatment to stabilize physiological functions. Continuous monitoring of liver and renal function in a hospital setting is officially required following overdosage. This profile ensures all risks, including those related to hepatic impairment, are addressed.

Therapeutic Uses of Dolaren

What Dolaren Treats: Main Uses and Benefits

Dolaren is relevant for managing multiple symptoms that occur together, providing symptomatic support across the axes of pain, inflammation, and fever. As a combination of agents including NSAIDs and Acetaminophen, the medicine is commonly used to help manage the symptoms of pain, fever, and inflammation concurrently. These classes of medicines are utilized for easing symptoms related to headaches, muscle aches, arthritis, and other common discomforts. This strategic approach supports managing symptom clusters that may become intense or disruptive.


The medication is considered relevant in conditions presenting with systemic or localized discomfort, applied across domains where additional symptomatic support is needed. It is commonly used for symptoms associated with osteoarthritis, rheumatoid arthritis, acute manifestations like post-traumatic pain, and primary dysmenorrhea (menstrual cramps).

“This approach helps ease the overall symptom burden, providing support that helps patients cope more steadily with difficult episodes.”

The combination helps improve day-to-day comfort during symptomatic periods, and is relevant for easing the impact of symptoms that interfere with routine activities.


Quick Fact: Supportive Management of Key Symptoms
Primary Focus Concurrent management of pain, fever, and inflammation.
Key Indications Musculoskeletal pain, acute trauma discomfort, and joint symptoms.
Core Benefit Helps ease the overall symptom burden and provides supportive relief.

Regulatory References

  1. NIH MedlinePlus overview of Pain Relievers

Eligibility and Restrictions for Use

Who Can and Cannot Use Dolaren?

Dolaren is a fixed-dose combination containing Acetaminophen, Diclofenac, and Ibuprofen. Regulatory labeling defines strict rules for its use, primarily based on the contraindications of its NSAID components.

The medicine is contraindicated and must not be used by patients with known hypersensitivity to any component or other NSAIDs, those with active gastrointestinal ulceration or hemorrhage, or individuals with severe hepatic or renal impairment. Absolute prohibition also applies to patients with severe heart failure (NYHA Class IV) and women in the third trimester of pregnancy.

Use is not established in children under 12 years of age. Older adults are permitted to use the medicine but are strictly advised to use the lowest effective dose for the shortest possible duration due to increased risk of adverse events. Conditional use restrictions apply to patients with mild to moderate organ impairment and those with cardiovascular risk factors (e.g., hypertension, mild heart failure). The medicine is generally not recommended for women who are breastfeeding. This official eligibility profile dictates exclusion for high-risk populations and conditional use for vulnerable groups.

What should I know about interactions with other medicines?

Official Interaction Constraints

Dolaren is a fixed-dose combination product containing Acetaminophen, Diclofenac, and Ibuprofen. Its interaction profile is determined by the regulatory restrictions documented for its three active components.

Constraint or Classification Regulatory Basis
Formal Contraindication Use of the NSAID components is contraindicated for treating pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Prohibited Co-administration Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) is not recommended due to a documented, substantially increased risk of serious gastrointestinal (GI) adverse events (e.g., bleeding, ulceration).
Alcohol Interaction Consumption of alcohol is associated with an increased risk of GI adverse events from the NSAID components and a specific increased risk of liver toxicity associated with Acetaminophen.

Clinically Significant Interactions

Regulatory documentation describes several significant interaction types, primarily classified by their resulting outcome on patient safety or drug exposure:

  • Additive Bleeding Risk: Co-administration with agents that increase bleeding risk, such as Anticoagulants (e.g., Warfarin), Antiplatelet agents, Oral Corticosteroids, and certain antidepressants (SSRIs/SNRIs), leads to a documented increased risk of serious bleeding or ulceration.
  • Exposure Modification: The NSAID components may increase the plasma concentrations of agents like Lithium and Methotrexate by reducing their renal clearance, potentially leading to increased systemic exposure of the co-administered drug.
  • Impaired Therapeutic Response: The NSAID components may impair the antihypertensive response of Diuretics and certain blood pressure medications (ACE Inhibitors and ARBs). Co-administration with these agents may also increase the risk of renal injury in certain patient populations.

Mechanism of Action

Inflammatory Pathway Modulation

Dolaren exhibits modulation of the inflammatory cascade, influencing key inflammatory pathways. Its primary action involves the inhibition of prostaglandin production through competitive antagonism of Cyclooxygenase (COX) enzymes. This interaction is the basis for influencing the biochemical pathways that propagate inflammation.

Influence on Articular Cartilage

The compound demonstrates a secondary mechanistic activity by reducing the activity of matrix metalloproteinases (MMPs), a group of enzymes that act upon articular cartilage. Additionally, the compound upregulates certain growth factors associated with tissue repair processes, affecting tissue remodeling pathways.

Downstream Molecular Effects

This dual mechanism results in the overall reduction of circulating biochemical markers of inflammation. The specialized delivery method influences the compound's systemic distribution, contributing to focused enzymatic activity within the target area.

Dosage and Administration Information

Instruction Map: How to use Dolaren — Administration Guidelines

This map compiles the usage instructions for Dolaren, focusing on administration parameters.

Instruction Detail
Route of administration Oral Ingestion of the fixed-dose combination (FDC) tablet or caplet.
Dosing schedule Administration follows the Lowest Effective Dose (LED) principle. The regimen is limited by the Maximum Daily Dose Constraint established for its components, ensuring total daily Acetaminophen intake from all sources does not exceed 4,000 mg.
Timing in relation to meals (if applicable) The dose may be taken with food or milk to potentially mitigate gastrointestinal discomfort, consistent with common NSAID administration practice.
Age-group administration rules Older Adults: Treatment should begin at the lowest end of the dosing range. Pediatric (Under 12): Use and dosing must be guided by medical direction.
Special procedural conditions Concomitant Use Restriction: Guidelines prohibit concurrent administration with any other products containing Acetaminophen or any other NSAID.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern As-Needed (PRN) in a divided schedule, typically every 6 to 8 hours.
Use-context constraints Shortest Duration Possible: Use is limited to the briefest course necessary for acute symptom management.

Resulting Procedural Structure

General step sequence:

  • Administer the fixed-dose oral tablet by swallowing the unit whole.
  • Maintain the dosing interval (e.g., 6 to 8 hours) and verify the maximum daily dose is not exceeded.
  • Crucially, ensure that no other products containing Acetaminophen or any NSAID are taken concurrently.

Connection to the overall use protocol: The instructions define the standardized oral administration of this fixed-dose combination, prioritizing control over component intake. This protocol establishes constraints on dosing frequency and total daily amounts, ensuring the medicine is used within the parameters specified for these active ingredients.

Recent Clinical Evidence

Research evidence / Overview of studies for Dolaren

The research surrounding Dolaren, a medicine combining two types of NSAIDs (Diclofenac and Ibuprofen) and Acetaminophen, primarily draws from studies on how the combined ingredients were evaluated in relation to symptom patterns. This overview describes the kinds of research that have explored these combined ingredients and what the findings, according to official sources, suggest about their use.


Evidence for Use in Acute Pain and Inflammation

Studies conducted during periods of heightened symptom activity have evaluated combination products similar to Dolaren in research exploring short-term symptom changes related to sudden discomfort. These often take the form of short-term Randomized Controlled Trials (RCTs) examining outcomes related to physical discomfort. Findings describe patterns observed in the studies where some combined treatments was associated with measurements of change in pain intensity in the first few hours compared to taking a placebo. Studies monitored the time to first observed change in symptom intensity and measured the overall change in outcomes during the observation period. Follow-up durations were limited, meaning most evidence focuses only on immediate relief rather than observations of the full course of recovery from the acute condition.


Evidence for Use in Chronic Musculoskeletal and Joint Pain

The research examined outcomes related to physical discomfort in conditions characterized by fluctuating or episodic manifestations, such as osteoarthritis. This evidence relies mainly on data for the individual active components—Diclofenac and Ibuprofen—rather than the specific three-way combination product. Studies report how symptoms evolved in the observed populations. Findings indicate that NSAIDs was associated with changes measured during the study period in patient-reported outcomes describing perceived discomfort and functional ability over several weeks. There is limited information for long-term outcomes specifically for the continuous use of this particular oral three-agent combination.


Research Gaps and Unanswered Questions

Evidence is limited in several key areas. Comparative evidence is lacking for the specific three-agent oral combination when studies examined it against other common two-agent FDC analgesics in head-to-head clinical trials. While Pharmacokinetic (PK) studies provide insight into absorption, research does not determine whether an individual will respond similarly in terms of outcomes related to physical discomfort or daily functioning. Furthermore, long-term effects are not fully established for the continuous use of the triple combination, and study results reflect the specific conditions under which they were conducted. Findings describe group patterns, not personal outcomes.

Key Studies & References Pain Relievers – MedlinePlus (General Overview of Analgesic Classes)

Frequently Asked Questions (FAQ)

Common questions about Dolaren (FAQ)


Q: Is it okay to use Dolaren with natural health supplements?

Official documents advise caution when combining this medicine with natural health products or supplements. Some supplements may not have undergone the same testing as prescription medicines, and combining them with the active ingredients in Dolaren may be associated with an increased risk of certain adverse events, such as bleeding.


Q: Can Dolaren be used by elderly patients?

Use by older adult patients is addressed in official prescribing information, which includes specific precautions. Regulatory guidance states that this group is at a greater risk for serious adverse events, including gastrointestinal issues. For this reason, official information states that use should adhere to the lowest effective dose for the shortest necessary duration.


Q: What makes Dolaren different from over-the-counter anti-inflammatory medicines?

This medicine is formulated as a specific Fixed-Dose Combination containing three active ingredients: Acetaminophen, Diclofenac, and Ibuprofen. Because it includes oral Diclofenac, its oral forms are generally classified as prescription-only medications. This composition differs from many common over-the-counter anti-inflammatory medicines, which typically contain a single active ingredient.


Q: What is the difference between a topical product like Dolaren and an oral tablet?

Dolaren is an oral tablet formulation designed to be swallowed, meaning its active ingredients are absorbed into the bloodstream. This is different from topical products, which are applied to the skin and are generally associated with a lower rate of systemic absorption.


Q: Is it possible to become dependent on Dolaren?

Official information classifies this medicine as a combination analgesic and anti-inflammatory agent. The active ingredients—Acetaminophen, Diclofenac, and Ibuprofen—are not classified as controlled substances or habit-forming medicines.


Q: Why is Dolaren sometimes listed as a Schedule drug?

In many regulatory systems, this medicine is classified as a prescription-only drug. This designation is used to indicate that the medicine is intended for use under the supervision of a healthcare professional due to the potential risk profile associated with its active components.


Q: What kind of studies support the use of Dolaren?

Studies and official information indicate that research includes short-term studies, often in the form of Randomized Controlled Trials (RCTs), examining outcomes related to measurements of change in physical discomfort. Evidence is generally focused on the immediate effects observed from combination analgesic use.


Q: How quickly does Dolaren start to work after using it?

Regulatory documents report that observed changes in discomfort intensity typically begin within the first few hours following administration.


Q: How long does the effect of one use of Dolaren typically last?

The measured duration of action is described in relation to the medicine's stated frequency of use. Official guidance indicates that administration is limited to every six to eight hours.


Q: Does using Dolaren make you drowsy or tired?

Official product information lists nervous system disorders as a class of possible adverse reactions, which can include effects such as dizziness and headache. Official information advises caution regarding the performance of tasks requiring mental alertness until a person knows how the medicine affects them.


Q: Can I drive or operate machinery after using Dolaren?

Official patient information describes that caution is needed when engaging in activities requiring complete mental alertness, such as driving or operating machinery, until an individual is aware of the medicine's effects. This relates to the potential for nervous system-related adverse reactions.


Q: Is Dolaren available without a prescription?

The oral formulation of this medicine is classified as a prescription-only drug in most regulatory jurisdictions. This is due to the composition and potential risk profile of its active ingredients, which means its use is typically overseen by a healthcare professional.


Q: Why does the packaging for Dolaren include a sun sensitivity warning?

Regulatory information notes that some patients may experience an increased sensitivity to the sun while using the medicine. This potential adverse reaction is known as photosensitivity. Regulatory information typically describes measures related to sun exposure, such as limiting time in the sun, avoiding tanning beds, and using protective clothing or sunscreen.


Q: What is the purpose of the inactive ingredients in Dolaren?

Inactive ingredients, also known as excipients, are listed in the official drug information. These components are necessary to provide the proper structure, texture, color, and stability to the final oral tablet formulation.


Q: Does Dolaren affect fertility?

Regulatory information advises that Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which are components of this medicine, may be associated with a reversible delay in ovulation for females of reproductive potential. This information is included in official regulatory documentation.


Q: Is it normal to feel a burning sensation when applying Dolaren?

The official administration route for this medicine is oral, meaning it is swallowed as a tablet, not applied to the skin. Because the product is not topical, official regulatory information does not address skin sensations upon application, clarifying this common misconception.


Q: Why are there different strengths of Dolaren available?

The medicine is supplied in various strengths to allow for administration according to the lowest effective dose principle. This approach, guided by a healthcare professional, supports tailoring the dosage to the individual needs and tolerability of the patient.

How should Dolaren be stored and disposed of?

How to Store and Dispose of Dolaren?

Official regulatory guidelines for this oral analgesic formulation focus on maintaining product stability and ensuring safety.

Mandatory Storage Conditions

The tablets must be stored at controlled room temperature, typically defined as 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and should be kept in its original container, which must be kept tightly closed. A mandatory requirement for all medicines is that Dolaren must be stored securely out of the sight and reach of children.

Official Disposal Procedures

Disposal of unused or expired tablets must follow government regulations. The preferred method is to use an authorized drug take-back program. If this is unavailable, the product must be mixed with an unappealing material, placed in a sealed container, and disposed of in the household trash; the medicine must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dolaren found in:

A-Z Index: